Literature DB >> 11745555

In vitro stability of a novel compliant poly(carbonate-urea)urethane to oxidative and hydrolytic stress.

Henryk J Salacinski1, Nigel R Tai, Robert J Carson, Alan Edwards, George Hamilton, Alexander M Seifalian.   

Abstract

Poly(ester)urethane and poly(ether)urethane vascular grafts fail in vivo because of hydrolytic and oxidative degradative mechanisms. Studies have shown that poly(carbonate)urethanes have enhanced resistance. There is still a need for a viable, nonrigid, small-diameter, synthetic vascular graft. In this study, we sought to confirm this by exposing a novel formulation of compliant poly(carbonate-urea)urethane (CPU) manufactured by an innovative process, resulting in a stress-free. Small-diameter prosthesis, and a conventional poly(ether)urethane Pulse-Tec graft known to readily undergo oxidation in a variety of degradative solutions, and we assessed them for the development of oxidative and hydrolytic degradation, changes in elastic properties, and chemical stability. To simulate the in vivo environment, we used buffered solutions of phospholipase A(2) and cholesterol esterase; solutions of H(2)O(2)/CoCl(2), t-butyl peroxide/CoCl(2) (t-but/CoCl(2)), and glutathione/t-butyl peroxide/CoCl(2) (Glut/t-but/CoCl(2)); and plasma fractions I-IV, which were derived from fresh human plasma centrifuged in poly(ethylene glycol). To act as a negative control, both graft types were incubated in distilled water. Samples of both graft types (100 mm with a 5.0-mm inner diameter) were incubated in these solutions at 37 degrees C for 70 days before environmental scanning electron microscopy, radial tensile strength and quality control, gel permeation chromatography, and in vitro compliance assessments were performed. Oxidative degradation was ascertained from significant changes in molecular weight with respect to a control on all Pulse-Tec grafts treated with t-but/CoCl(2), Glut/t-but/CoCl(2), and plasma fractions I-III. Pulse-Tec grafts exposed to the H(2)O(2)/CoCl(2) mixture had significantly greater compliance than controls incubated in distilled water (p < 0.001 at 50 mmHg). No changes in molecular weight with respect to the control were observed for the CPU samples; only those immersed in t-but/CoCl(2) and Glut/t-but/CoCl(2) showed an 11% increase in molecular weight to 108,000. Only CPU grafts treated with the Glut/t-but/CoCl(2) mixture exhibited significantly greater compliance (p < 0.05 at 50 mmHg). Overall, results from this study indicate that CPU presents a far greater chemical stability than poly(ether)-urethane grafts do. Copyright 2001 John Wiley & Sons, Inc. J Biomed Mater Res 59: 207-218, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11745555     DOI: 10.1002/jbm.1234

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  5 in total

Review 1.  Engineering of bypass conduits to improve patency.

Authors:  S T Rashid; H J Salacinski; B J Fuller; G Hamilton; A M Seifalian
Journal:  Cell Prolif       Date:  2004-10       Impact factor: 6.831

Review 2.  Tissue-engineered heart valve: future of cardiac surgery.

Authors:  Radoslaw A Rippel; Hossein Ghanbari; Alexander M Seifalian
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

3.  High compliance vascular grafts based on semi-interpenetrating networks.

Authors:  David K Dempsey; Roya M Nezarati; Calvin E Mackey; Elizabeth M Cosgriff-Hernandez
Journal:  Macromol Mater Eng       Date:  2014-12       Impact factor: 4.367

4.  Patency rate and complications of polytetrafluoroethylene grafts compared with polyurethane grafts for hemodialysis access.

Authors:  Hassan Ravari; Gholam Hossein Kazemzade; Mohammad Hadi Saied Modaghegh; Patricia Khashayar
Journal:  Ups J Med Sci       Date:  2010-03-11       Impact factor: 2.384

5.  In vitro Endothelialization and Platelet Adhesion on Titaniferous Upgraded Polyether and Polycarbonate Polyurethanes.

Authors:  Karla Lehle; Jing Li; Hanngörg Zimmermann; Björn Hartmann; Daniel Wehner; Thomas Schmid; Christof Schmid
Journal:  Materials (Basel)       Date:  2014-01-24       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.